Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/02/2008 | WO2008051620A2 Methods and compositions for intracytoplasmic sperm injection-mediated transgenesis |
05/02/2008 | WO2008051306A1 Soluble tnf receptors and their use in treatment of disease |
05/02/2008 | WO2008051039A1 Method for detecting nucleotide variations |
05/02/2008 | WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
05/02/2008 | WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
05/02/2008 | WO2008050870A1 Organ-specific gene, method for identifying the same and use thereof |
05/02/2008 | WO2008050855A1 Gene sensitive to bone/joint disease and use thereof |
05/02/2008 | WO2008050825A1 Method of producing basement membrane collagen |
05/02/2008 | WO2008050774A1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
05/02/2008 | WO2008050329A2 Novel sirnas and methods of use thereof |
05/02/2008 | WO2008049865A2 Methods for increasing the resistance in plants to biotropic fungi |
05/02/2008 | WO2008049849A1 Maize with good digestibility and disease resistant |
05/02/2008 | WO2008049848A1 Maize with enhanced tolerance to fungal pathogens |
05/02/2008 | WO2008049837A2 Improved alpha factor signal peptide for producing a polypeptide |
05/02/2008 | WO2008049782A1 Method of increasing gene expression using modified codon usage |
05/02/2008 | WO2008049781A1 Method of reducing gene expression using modified codon usage |
05/02/2008 | WO2008049769A1 Alleles of the prpd1-gene from coryneform bacteria |
05/02/2008 | WO2008049638A1 Integrated microfluidic component for purifying analyte molecules and purification method |
05/02/2008 | WO2008049424A2 Pharmaceutical composition for the treatment of allergic diseases |
05/02/2008 | WO2008049230A1 Ptra gene and uses therefor |
05/02/2008 | WO2008049226A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions |
05/02/2008 | WO2008049225A1 Methods for diagnosing osteoarthritis |
05/02/2008 | WO2008049209A2 Endophyte enhanced seedlings with increased pest tolerance |
05/02/2008 | WO2008049183A1 Method for modifying plant architecture and enhancing plant biomass and/or sucrose yield |
05/02/2008 | WO2008030996A3 Sirna and methods of manufacture |
05/02/2008 | WO2008027986A3 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
05/02/2008 | WO2008026946A3 Compositions and methods for the treatment and prevention of neoplastic disorders |
05/02/2008 | WO2008025164A8 Family 6 cellulases with increased thermostability, thermophilicity, and alkalophilicity |
05/02/2008 | WO2008021574A3 Modulating plant carotenoid levels |
05/02/2008 | WO2008020654A3 An l-glutamic acid producing bacterium and a method for producing l-glutamic acid |
05/02/2008 | WO2008014979A3 NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT |
05/02/2008 | WO2008010864A3 Modified adenovirus hexon protein and uses thereof |
05/02/2008 | WO2008009977A3 Methods and compositions for modulating socs3 |
05/02/2008 | WO2008008967A3 Methods for increasing expression of genes in a fungal cell |
05/02/2008 | WO2008002470A3 Sirna sequences against brf1 |
05/02/2008 | WO2008000779A3 Polioma vector expressing long double-stranded rnas |
05/02/2008 | WO2007146706A3 Modified dicamba monooxygenase enzyme and methods of its use |
05/02/2008 | WO2007144775A3 Plants with increased tolerance to water deficit |
05/02/2008 | WO2007144621A3 Protection against and treatment of age related macular degeneration |
05/02/2008 | WO2007141580A3 Rnase h2 complex and genes therefor |
05/02/2008 | WO2007135194A9 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
05/02/2008 | WO2007130697A8 Anti-ephb4 antibodies and methods using same |
05/02/2008 | WO2007126764A3 Chemically modified viral capsids as targeted delivery vectors for diagnostic and therapeutic agents |
05/02/2008 | WO2007103382A3 Plant-specific genetic elements and transfer cassettes for plant transformation |
05/02/2008 | WO2007103307B1 Site-specific incorporation of amino acids into molecules |
05/02/2008 | WO2007096399A3 Selection of host cells expressing protein at high levels |
05/02/2008 | WO2007084237A3 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications |
05/02/2008 | WO2007056331A3 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
05/02/2008 | WO2007028573A9 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
05/02/2008 | WO2006026570A3 Use of stem cells to generate inner ear cells |
05/02/2008 | WO2000055303A3 Transgenic plants having imroved flavor properties |
05/02/2008 | CA2703124A1 Methods for diagnosing osteoarthritis |
05/02/2008 | CA2667699A1 Method for modifying plant architecture and enhancing plant biomass and/or sucrose yield |
05/02/2008 | CA2667582A1 Method of treating conditions associated with proteoglycan production |
05/02/2008 | CA2667568A1 Endophyte enhanced seedlings with increased pest tolerance |
05/02/2008 | CA2667558A1 Plants with improved nitrogen utilization and stress tolerance |
05/02/2008 | CA2667465A1 Maize with good digestibility and disease resistant |
05/02/2008 | CA2667462A1 Maize with enhanced tolerance to fungal pathogens |
05/02/2008 | CA2667263A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
05/02/2008 | CA2667099A1 Cropping systems for managing weeds |
05/02/2008 | CA2667019A1 Antibodies and immunoconjugates and uses therefor |
05/02/2008 | CA2666981A1 Soluble tnf receptors and their use in treatment of disease |
05/02/2008 | CA2666672A1 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
05/02/2008 | CA2666517A1 Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
05/02/2008 | CA2666270A1 Novel sirnas and methods of use thereof |
05/02/2008 | CA2662610A1 Improved alpha factor signal peptide for producing a polypeptide |
05/02/2008 | CA2660439A1 Methods for increasing the resistance in plants to biotropic fungi |
05/02/2008 | CA2608923A1 Non-metallic laboratory implement and method of its use |
05/01/2008 | US20080104734 Recombinant antibodies to sclerotinia antigens |
05/01/2008 | US20080104733 Transgenic cells comprising nucleotide sequences coding hydrolase for propagation of salt resistant plants |
05/01/2008 | US20080104732 Methods and means for obtaining modified phenotypes |
05/01/2008 | US20080104731 Second TC complex from Xenorhabdus |
05/01/2008 | US20080104730 Recombinant DNA construct which expresses Hap3 transcription factor which provides resistance to drought and herbicides |
05/01/2008 | US20080104729 Nucleic acid molecules and other molecules associated with plants |
05/01/2008 | US20080104728 Nucleic acid encoding polypeptide of given sequence; modulating pyruvate dehydrogenase kinase using recombinant expression cassettes; |
05/01/2008 | US20080104726 Fruit regulatory regions |
05/01/2008 | US20080104725 Regenerating transformed seeds using chimeric nucleic acid construct; transcription; increased proteins, decreased lipids |
05/01/2008 | US20080104724 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars |
05/01/2008 | US20080104723 Development of Mammalian Genome Modification Technique Using Retrotransposon |
05/01/2008 | US20080104721 Nucleic acids isolated from crustaceans; linked to expression regulatory elements; analyzing cells by detection of signal; kits |
05/01/2008 | US20080104718 Transgenic Non-Human Animal Models of Ischemia-Reperfusion Injury and Uses Thereof |
05/01/2008 | US20080103297 Solid-phase extraction using particles coated on adhesive; separation of polymerase chain reaction reagents, residual primes, dyes |
05/01/2008 | US20080103113 Reduced level of background gene expression; responds to submicromolar concentrations of nonsteroidal ligand |
05/01/2008 | US20080103109 Distributing polynucleotide in vivo using conditional vector that is transcriptionally active in normal cells and not in malfunctioning cells |
05/01/2008 | US20080103108 Targeted artificial gene delivery |
05/01/2008 | US20080103106 Compositions and their uses directed to il-4r alpha |
05/01/2008 | US20080103099 Apoptin-associating protein |
05/01/2008 | US20080103098 Recombinant Expression of Proteins in a Disulfide-Bridged, Two-Chain Form |
05/01/2008 | US20080103095 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
05/01/2008 | US20080103090 Polynucleotide; hybridization; recombinant vectors, host cells; diagnosis, prognosis; anticarcinogenic and antiproliferative agents; drug screening; genetic engineering |
05/01/2008 | US20080103088 Combating disorders affecting mitochondrial oxidative phosphorylation system by allotopic expression of the cyanide-insensitive alternative oxidase (AOX) in human cells; polynucleotide obtained from Mollusca, Nematoda and Chordata; metabolic, cardiovascular, genetic, and nervous system disorders |
05/01/2008 | US20080103087 Azurin, pseudoazurin, plastocyanin, rusticyanin, Laz or auracyanin from Xylella, Pseudomonas, Alcaligene, Achromobacter, Bordetella, Methylomonas, Neisseria, or Vibrio; anticarcinogenic or antitumor agents; diabetic retinopathy, rheumatoid arthritis, psoriasis |
05/01/2008 | US20080103061 Functionalized compositions for improved immobilization |
05/01/2008 | US20080103059 Microcolumn-platform based array for high-throughput analysis |
05/01/2008 | US20080103055 Polypeptide |
05/01/2008 | US20080102524 Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity |
05/01/2008 | US20080102523 Plasmid comprising nucleotide sequences coding matrix attachment region (MAR) for use in animal cell; improving heterologous gene expression |
05/01/2008 | US20080102520 Novel human membrane proteins and polynucleotides encoding the same |
05/01/2008 | US20080102519 Apparatus and method for preparative scale purification of nucleic acids |
05/01/2008 | US20080102510 Transgenic cells for use as bioreactors in expression of amidated peptides |